Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
It’s a Wrap! NETS Autumn Forums Update with Trends for 2023
Here is a look back at the recent NETS forums, giving you insights and a deeper dive into the trends that detail an evolving biopharma landscape.
NETS - Platform for Insights to Effect Change and Mitigate Risk
Gaining insights is not just a buzzword but a decisive movement towards access to vital information that can pave the way for efficient management of clinical trials. The COVID-19 pandemic brought to the fore the importance of carrying out collaborative research. NETS has advocated such access to insights from across the industry for over 20 years, realising the importance of leveraging knowledge gained from prior experience.
Our family of networks provides an independent community for business leaders facing similar challenges. Members exchange insights, compare performance, and debate strategies to tackle any issues they may face.
What Happened in our NETS Autumn Forums?
Our forums have always illuminated the way forward in terms of themes, trends, and collective storylines that resonate with the entire life sciences industry. The Autumn forums, 3 face-to-face and 9 virtual events, brought with it its fair share of industry insights and some great discussions that threw up some exciting resources.
a. Wide Participation and Indepth Discussions
Our peer-to-peer networks have been gaining momentum and actively supported by industry architects and peers alike. The recent forum saw continued support, with case studies being analysed and more than an 80% engagement rate.
b. Impressive Value additions and Rating: When the NETS forum insights are utilized appropriately, they help in contextualizing and scrutenizing factors, adding value. Explore our ‘Value Report card’ below for a sneek peak into potentially gainful interactions.
c. Trends in 2023: An important aspect to preparing for the future is to have a pulse on what may come next. The autumn forum of NETS discussed interesting topics, and the way forward.
One topic dominating the minds of industry leaders at the forum is “What organizational strategies to adopt?” Two of our Thought Leads Tris and Latika, share their reflections on the conundrums and strategies our members are adopting.
Labeling’s next conundrum – how to step up in an increasingly challenging environment?
Regulatory is on the front line to deliver submissions in increasingly condensed timeframes and labeling, as a critical function, must continue to lead the way through streamlined processes, leveraging collaborations and innovation in technology to deliver high-quality, timely outputs. This must be done while navigating an elevated workload, a perplexing maze of Health Authority requirements, sub-optimal technology, and a highly competitive resource market. So, how are companies adapting their approaches to achieve this?
Creating a seamless partnership between labeling and clinical colleagues is an obvious opportunity. Engaging labeling strategists early in the clinical development program not only allows shaping of the clinical trial design to ensure optimal language in the final label, but also gives labeling a head-start on CCDS and key market label creation. Whilst labeling strives to be embedded in the product development lifecycle as early as practicable, there is also a trend to differentiate ownership of strategic labeling activities more clearly from the work of the regulatory strategists. This helps to ensure the unique and valuable perspective of labeling is included as part of the product commercial strategy and not just seen as the leaflet in the box.
Tris Nockles,
Regulatory Networks Thought Lead,
Navitas Life Sciences
Companies are also optimizing their labeling organizational structures to better align with other functions. Emerging trends include some divergent approaches, while companies explore different operating models:
So, what does all this mean for our labeling organizations in the next 5 years? Will we continue to see our traditional functional construct, or could the operating model be more distributed? Will technology finally fulfil its promise, and can the strategic contribution of labeling be recognized within the broader organization?
Co-creation comes of age – PV strategies in action
Partner beyond borders (new functions and interfaces)
It often takes a Black Swan event like COVID-19 to accelerate not only innovate, but also change business models - the COVID-19 vaccine is indeed a testimony to the fact that indeed regulators, the medical community, and the pharma industry can do whatever it takes for the greater good for the patients.
Consequently, 71% of pvnet members interface with patient affairs department, 100% of PV organizations have incorporated data and digital initiatives. These initiatives are multi-disciplinary, often with bridge roles to ‘’translate’’ information and technology into the scientific and business context and vice versa. This involves a fundamental change in mindset, becoming more agile.
Latika Sharma,
PV Networks Thought Lead,
Navitas Life Sciences
Collaborate or integrate
For most PV organizations, investments are limited, particularly for novel ventures with uncertain ROI. It makes sense to pool resources (skills, data, infrastructure, project management, etc.); these can be enterprise or external (consortiums, public-private partnerships, academia, etc.) In rare diseases, Cell & Gene therapy, where patients are so few, collaboration for the exchange of data and insights can help bring medicines to market faster. Collaboration is a given; question of integration (e.g. PV + regulatory/Pharma + technology) depends on what competitive advantage it will give.
Learn more about each network
A network for Heads of Safety and Senior Leaders of Top 25 life sciences companies, investing in thought leadership to help shape future practices
A network for Heads of Labeling of top 30 life sciences companies, investing in thought leadership to help shape future practices
A network for PV professionals of mid-sized life sciences companies to collaborate in strategic thinking and share best practices
A network for Labeling IT Professionals and Business Leads focused on exploring End-to-End Labeling technologies to improve business processes and increase business value
A network for Heads of Information Technology for PV departments, focused on increasing business value from technology investments
A network for Business and Technology Leaders to collaborate on best practices and leading-edge solutions for Regulatory Information Management
A network For Heads of Safety and PV Leadership of Indian life sciences companies and multi-nationals with a presence in the Indian market
A unique peer-to-peer network for Chief Medical Officers to discuss trends and insights, exchange innovative ideas, and offer best practices
Why should you become a member of our Industry Leading Networks
10 Reasons to become a NETS Member - Established in 2001, our networks community is the place to discuss trends, insights, and future solutions.
Find out why you should become a member: https://www.navitaslifesciences.com/10-reasons-to-become-a-nets-member
To learn more about our services and solutions, reach out to us at